Similar articles

• [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].

  Janot C. Janot C. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):347-50. doi: 10.1016/s1140-4639(05)80042-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177596 French. No abstract available.
• [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].

  Jullien AM, Courouce AM, Maniez M, Brevière D, Menault M, Finetti P, Girard M. Jullien AM, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):355-8. doi: 10.1016/s1140-4639(05)80044-9. Rev Fr Transfus Hemobiol. 1990. PMID: 2177598 French. No abstract available.
• [HCV antibodies in selected patient groups and blood donors].

  Courault K, Lisse C, Ehrenberg M, Stolle K, Brandstädter W, Fritzsche L. Courault K, et al. Beitr Infusionsther. 1991;28:22-4. Beitr Infusionsther. 1991. PMID: 1725624 Clinical Trial. German.
• [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].

  Couroucé AM. Couroucé AM. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):335-8. doi: 10.1016/s1140-4639(05)80039-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177594 Review. French. No abstract available.
• [Post-transfusional hepatitis].

  González A, Esteban JI. González A, et al. Sangre (Barc). 1993 Jun;38(3):193-200. Sangre (Barc). 1993. PMID: 7692610 Review. Spanish. No abstract available.